Listed

Ryder System Inc: Form 10-Q for the period ended Sep 30, 2024

Filed with the SEC on Oct 24, 2024 and accepted by EDGAR at Oct 24, 2024, 12:28 ET.

Share

Management's discussion and analysis

As filed, 1,537 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following table provides information with respect to purchases we made of our common stock during the three months ended September 30, 2024:

(Dollars in millions, except per share)

Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Programs Aggregate Maximum Number of Shares That May Yet Be Purchased Under the Anti-Dilutive Program (1)
July 1 through July 31, 2024 242,963 $131.21 242,963 2,047,062
August 1 through August 31, 2024 700,160 136.66 700,160 1,346,902
September 1 through September 30, 2024 100,382 136.89 100,188 1,246,714
Total 1,043,505 $135.41 1,043,311

(1) We currently maintain two share repurchase programs approved by our board of directors in October 2023 and October 2024. Refer to Note 9, “Share Repurchase Programs,” in the Notes to Condensed Consolidated Financial Statements for a discussion on our share repurchase programs. Share repurchases can be made from time to time using our working capital and a variety of methods, including open-market transactions and trading plans established pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934. The timing and actual number of shares repurchased are subject to market conditions, legal requirements and other factors, including balance sheet leverage, availability of quality acquisitions and stock price.

Market risk

As filed, 213 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to Ryder's exposures to market risks since December 31, 2023. Please refer to the 2023 Annual Report on Form 10-K for a complete discussion of Ryder's exposures to market risks.

Controls and procedures

As filed, 1,010 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the third quarter of 2024, we carried out an evaluation, under the supervision and with the participation of management, including Ryder's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that as of the end of the third quarter of 2024, Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) were effective.

Changes in Internal Control over Financial Reporting

During the three months ended September 30, 2024, there were no changes in Ryder's internal control over financial reporting that have materially affected or are reasonably likely to materially affect such internal control over financial reporting.

Risk factors

As filed, 511 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

To our knowledge and except to the extent additional factual information disclosed in this Quarterly Report on Form 10-Q relates to such risk factors, there have been no material changes in the risk factors described in "Item 1A. Risk Factors" in our

Form 10-K for the year ended December 31, 2023, filed with the SEC on February 20, 2024. Our operations could also be affected by additional risk factors that are not presently known to us or by factors that we currently consider not material to our business.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-07-01 to 2024-09-30$3.17bnus-gaap:Revenues
Revenue9 months2024-01-01 to 2024-09-30$9.45bnus-gaap:Revenues
Selling, general and administrative3 months2024-07-01 to 2024-09-30$368.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2024-01-01 to 2024-09-30$1.11bnus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2024-07-01 to 2024-09-30$98.0mus-gaap:InterestExpense
Interest expense9 months2024-01-01 to 2024-09-30$286.0mus-gaap:InterestExpense
Income tax3 months2024-07-01 to 2024-09-30$45.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-01-01 to 2024-09-30$126.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-07-01 to 2024-09-30$142.0mus-gaap:NetIncomeLoss
Net income9 months2024-01-01 to 2024-09-30$354.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-07-01 to 2024-09-30$3.24us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-01-01 to 2024-09-30$7.95us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-07-01 to 2024-09-30$3.30us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-01-01 to 2024-09-30$8.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-07-01 to 2024-09-3043,885,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-01-01 to 2024-09-3044,506,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-01-01 to 2024-09-30$1.71bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2024-07-01 to 2024-09-30$599.0mus-gaap:PaymentsToAcquireProductiveAssets
Capital expenditure9 months2024-01-01 to 2024-09-30$1.92bnus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid9 months2024-01-01 to 2024-09-30$101.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2024-01-01 to 2024-09-30$282.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-09-30$162.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-09-30$2.38bnus-gaap:AssetsCurrent
Total assetsAt period end2024-09-30$16.50bnus-gaap:Assets
Current liabilitiesAt period end2024-09-30$3.21bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-09-30$13.44bnus-gaap:Liabilities
Current portion of debtAt period end2024-09-30$975.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2024-09-30$3.06bnus-gaap:StockholdersEquity
Shares outstandingAt period end2024-09-3042,290,213 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000085961-24-000156. Last ingested by Listed: Nov 14, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.